<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To describe the status of glycaemic control, self-reported adherence to treatments, psychological well-being and quality of life in Chinese patients with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in 2006 </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Subjects having registered for care for &gt; 12 months at a <z:mp ids='MP_0002055'>diabetes</z:mp> clinic were enrolled in this study </plain></SENT>
<SENT sid="2" pm="."><plain>Glycaemic control was determined by HbA(1c) and plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> levels; information about self-reported adherence to treatments was obtained by questionnaire; psychological well-being was assessed by use of a modified World Health Organization-5 Well-being Index; and quality of life was measured by use of a modified <z:mp ids='MP_0002055'>Diabetes</z:mp> Attitudes, Wishes and Needs (DAWN) survey </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> data were tabulated and statistical analyses were performed </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: A total of 2702 patients were enrolled during 2006 </plain></SENT>
<SENT sid="5" pm="."><plain>Only 23% of patients achieved an HbA(1c) level of &lt; 48 mmol/mol (6.5%) as per the 2007 China guideline for Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and only 16.2% followed <z:hpo ids='HP_0000001'>all</z:hpo> treatment recommendations from healthcare providers </plain></SENT>
<SENT sid="6" pm="."><plain>Of the patients, 46.0-68.6% of the patients showed positive psychological well-being </plain></SENT>
<SENT sid="7" pm="."><plain>A quality-of-life survey showed that 28.5-50.6% of the patients experienced various <z:mp ids='MP_0002055'>diabetes</z:mp>-related emotional problems </plain></SENT>
<SENT sid="8" pm="."><plain>Large percentages (approximately 50%) of patients were experiencing psychological <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Although in China therapies for Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are more effective and available than ever before, the patient outcomes remain disappointing </plain></SENT>
<SENT sid="10" pm="."><plain>Problems with glycaemic control, self-reported adherence to treatments, psychological well-being and quality of life, <z:hpo ids='HP_0000001'>all</z:hpo> of which are key to <z:mp ids='MP_0002055'>diabetes</z:mp> control, are common among Chinese patients with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>